Methods for diagnosis of bile acid malabsorption in clinical practice

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 10, 2013, Pages 1232-1239

  Vijayvargiya, Priya ^a   Camilleri, Michael ^a   Shin, Andrea ^a   Saenger, Amy ^b  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

C4; Diarrhea; Fecal; Glycocholate; SeHCAT

Indexed keywords

7 ALPHA HYDROXY 4 CHOLESTEN 3 ONE; ALPHA HYDROXY 4 CHOLESTEN 3 ONE; BILE ACID; CHENODEOXYCHOLIC ACID; CHOLEST 4 EN 3 ONE; CHOLIC ACID; DEOXYCHOLIC ACID; FECES LIPID; GLYCOCHOLIC ACID C 14; RADIOPHARMACEUTICAL AGENT; TAUROSELCHOLIC ACID SE 75; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

BACTERIAL OVERGROWTH; BILE ACID BLOOD LEVEL; BILE ACID MALABSORPTION; BREATH ANALYSIS; CHRONIC DIARRHEA; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); CONSTIPATION; DIAGNOSTIC TEST; DISEASE MARKER; ENTEROHEPATIC CIRCULATION; ENZYMATIC ASSAY; FECES ANALYSIS; FECES LEVEL; GLYCOCHOLATE C 14 BREATH TEST; GLYCOCHOLATE C 14 STOOL TEST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IRRITABLE COLON; MALABSORPTION; MASS FRAGMENTOGRAPHY; PATIENT COMPLIANCE; PREDICTIVE VALUE; RADIATION EXPOSURE; REVIEW; SMALL INTESTINE; TANDEM MASS SPECTROMETRY; TAUROSELCHOLIC ACID SE 75 ACID TEST; UNITED STATES;

(75)SEHCAT; (75)SELENIUM HOMOTAUROCHOLIC ACID TEST; 7 Α-HYDROXY-4-CHOLESTEN-3-ONE; ASBT; BA; BAM; BILE ACID; BILE ACID MALABSORPTION; C4; CA; CDCA; CHENODEOXYCHOLIC ACID; CHOLESTEROL 7Α HYDROXYLASE; CHOLIC ACID; CYP7A1; DCA; DEOXYCHOLIC ACID; DIARRHEA; FECAL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GC-MS; GLYCOCHOLATE; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HPLC; IBAT; IBS; ILEAL BA TRANSPORTER; IRRITABLE BOWEL SYNDROME; LCA; LITHOCHOLIC ACID; MASS SPECTROMETRY; MS; NA(+)-DEPENDENT BILE SALT TRANSPORTER; NADH; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SEHCAT;

BILE ACIDS AND SALTS; FECES; FEMALE; GASTROINTESTINAL TRANSIT; HUMANS; INTESTINES; IRRITABLE BOWEL SYNDROME; MALE;

EID: 84884354833     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.04.029     Document Type: Review

References (40)

1. Hofmann A.F., Small D.M. Detergent properties of bile salts: correlation with physiological function. Annu Rev Med 1967, 18:333-376.
2. Rao A.S., Wong B., Camilleri M., et al. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology 2010, 139:1549-1558.
3. Alnouti Y. Bile acid sulfation: a pathway of bile acid elimination and detoxification. Toxicol Sci 2009, 108:224-246.
4. Robben J., Caenepeel P., Van Eldere J., et al. Effects of intestinal microbial bile salt sulfatase activity on bile salt kinetics in gnotobiotic rats. Gastroenterology 1988, 94:494-502.
5. Breuer N.F., Rampton D.S., Tammar A., et al. Effect of colonic perfusion with sulfated and nonsulfated bile acids on mucosal structure and function in the rat. Gastroenterology 1983, 84:969-977.
6. Hofmann A.F. The syndrome of ileal disease and the broken enterohepatic circulation: cholerhetic enteropathy. Gastroenterology 1967, 52:752-757.
7. Wedlake L., A'Hern R., Russell D., et al. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009, 30:707-717.
8. Camilleri M., Nadeau A., Tremaine W.J., et al. Measurement of serum 7α-hydroxy-4-cholesten-3-one (or 7αC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil 2009, 21:734-734.e43.
9. Mekjian H.S., Phillips S.F., Hofmann A.F. Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. JClin Invest 1971, 50:1569-1577.
10. Bampton P.A., Dinning P.G., Kennedy M.L., et al. The proximal colonic motor response to rectal mechanical and chemical stimulation. Am J Physiol 2002, 282:G443-G449.
11. Chadwick V.S., Gaginella T.S., Carlson G.L., et al. Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon. JLab Clin Med 1979, 94:661-674.
12. Surowiec D., Kuyumjian A.G., Wynd M.A., et al. Past, present, and future therapies for Clostridium difficile-associated disease. Ann Pharmacother 2006, 40:2155-2163.
13. Weiss K. Toxin-binding treatment for Clostridium difficile: a review including reports of studies with tolevamer. Int J Antimicrob Agents 2009, 33:4-7.
14. Walters J.R., Tasleem A.M., Omer O.S., et al. Anew mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol 2009, 7:1189-1194.
15. Fromm H., Hoffman A. Breath test for altered bile-acid metabolism. Lancet 1971, 2:621-625.
16. Scarpello J.H.B., Sladen G.E. Appraisal of the 14C-glycocholate acid test with special reference to the measurement of faecal 14C excretion. Gut 1977, 18:742-748.
17. Van Tilburg A.J.P., de Rooij F.W.M., van den Berg W.O., et al. The selenium-75-homocholic acid taurine test reevaluated: combined measurement of fecal selenium-75 activity and 3α-hydroxy bile acids in 211 patients. JNucl Med 1991, 32:1219-1224.
18. Camilleri M., Brown M.L., Malagelada J.R. Impaired transit of chyme in chronic intestinal pseudo obstruction: correction by cisapride. Gastroenterology 1986, 91:619-626.
19. Ferguson J., Walker K., Thomson A.B. Limitations in the use of 14C-glycocholate breath and stool bile acid determinations in patients with chronic diarrhea. JClin Gastroenterol 1986, 8:258-262.
20. Sauter G.H., Munzing W., Von Ritter C., et al. Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7[alpha]-hydroxy-4-cholesten-3-one in serum. Dig Dis Sci 1999, 44:14-19.
21. Thaysen E.H., Orholm M., Arnfred T., et al. Assessment of ileal function by abdominal counting of the retention of a gamma emitting bile acid analogue. Gut 1982, 23:862-865.
22. Williams A.J., Merrick M.V., Eastwood M.A. Idiopathic bile acid malabsorption: a review of clinical presentation, diagnosis, and response to treatment. Gut 1991, 32:1004-1006.
23. Sciarretta G., Vicini G., Fagioli G., et al. Use of 23-selena-25-homocholyltaurine to detect bile acid malabsorption in patients with ileal dysfunction or diarrhea. Gastroenterology 1986, 91:1-9.
24. Notghi A., O'Brien J., Chen S.L., et al. Measuring SeHCAT retention: atechnical note. Nucl Med Commun 2011, 32:960-966.
25. al-Hadrani A., Lavelle-Jones M., Kennedy N., et al. Bile acid malabsorption in patients with post-vagotomy diarrhoea. Ann Chir Gynaecol 1992, 81:351-353.
26. Sciarretta G., Fagioli G., Furno A., et al. 75Se HCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit. Gut 1987, 28:970-975.
27. Axelson M., Aly A., Sjövall J. Levels of 7 alpha-hydroxy-4-cholesten-3-one in plasma reflect rates of bile acid synthesis in man. Fed Eur Biochem Sci 1988, 239:324-328.
28. Galman C., Arvidsson I., Angelin B., et al. Monitoring hepatic cholesterol 7α hydroxylase activity by assay of the stable bile acid intermediate 7α-hydroxy-4-cholesten-3-one in peripheral blood. JLipid Res 2003, 44:859-865.
29. Galman C., Angelin B., Rudling M. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. Gastroenterology 2005, 129:1445-1453.
30. Ma K., Xiao R., Tseng H., et al. Circadian dysregulation disrupts bile acid homeostasis. PLoS One 2009, 4:e6843-e6852.
31. Wong B.S., Camilleri M., Carlson P., et al. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol 2012, 10:1009-1015.
32. Shin A., Vijayvargiya P., Busciglio I., et al. Quantitative assessment of fecal primary and secondary bile acids in health and irritable bowel syndrome (IBS) with diarrhea or constipation. Gastroenterology 2013, 144(Suppl 1):S149-S150.
33. Abrahamsson H., Ostlund-Lindqvist A., Nilsson R., et al. Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation. Scand J Gastroenterol 2008, 43:1483-1488.
34. Porter J.L., Fordtran J.S., Santa Ana C.A., et al. Accurate enzymatic measurement of fecal bile acids in patients with malabsorption. JLab Clin Med 2003, 141:411-418.
35. Griffiths W.J., Sjövall J. Bile acids: analysis in biological fluids and tissues. JLipid Res 2010, 51:23-41.
36. Story J.A., Furumoto E.J. Bile acid analysis: methods and problems. Eur J Cancer Prev 1991, 1(Suppl 2):29-33.
37. Hofmann A.F., Loening-Baucke V., Lavine J.E., et al. Altered bile acid metabolism in childhood functional constipation: inactivation of secretory bile acids by sulfation in a subset of patients. JPediatr Gastroenterol Nutr 2008, 47:598-606.
38. Mitchell W.D., Findlay J.M., Prescott R.J., et al. Bile acids in the diarrhoea of ileal resection. Gut 1973, 14:348-353.
39. Setchell K.D., Ives J.A., Cashmore G.C., et al. On the homogeneity of stools with respect to bile acid composition and normal day-to-day variations: a detailed qualitative and quantitative study using capillary column gas chromatography-mass spectrometry. Clin Chim Acta 1987, 162:257-275.
40. Manabe N., Wong B.S., Camilleri M., et al. Lower functional gastrointestinal disorders: evidence of abnormal colonic transit ina 287 patient cohort. Neurogastroenterol Motil 2010, 22:293-293.e82.